Chris Sheldon, PhD, is a seasoned biopharmaceutical executive with over 20 years of experience, currently serving as Senior Vice President and Global Head of Business Development at GSK. Previously, Chris held various leadership roles at AstraZeneca, including Vice President of Global Business Development & Licensing in Oncology, where responsibilities included overseeing scouting and evaluation of in-licensing opportunities. Chris earned a PhD in Organic Chemistry from the University of Bristol and a Master's degree in Chemistry from the University of Sheffield. Throughout their career, Chris has demonstrated a commitment to innovation and collaboration in the biopharmaceutical sector.
This person is not in the org chart
This person is not in any teams
This person is not in any offices